CA1271751A - Dihydroimidazo[1,2-a]pyrimidine derivatives - Google Patents
Dihydroimidazo[1,2-a]pyrimidine derivativesInfo
- Publication number
- CA1271751A CA1271751A CA000481703A CA481703A CA1271751A CA 1271751 A CA1271751 A CA 1271751A CA 000481703 A CA000481703 A CA 000481703A CA 481703 A CA481703 A CA 481703A CA 1271751 A CA1271751 A CA 1271751A
- Authority
- CA
- Canada
- Prior art keywords
- group
- methyl
- pyrimidine
- dihydroimidazo
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP104257/84 | 1984-05-22 | ||
JP59104257A JPS60246387A (ja) | 1984-05-22 | 1984-05-22 | ジヒドロイミダゾ〔1,2−a〕ピリミジン誘導体 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA1271751A true CA1271751A (en) | 1990-07-17 |
Family
ID=14375875
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA000481703A Expired - Lifetime CA1271751A (en) | 1984-05-22 | 1985-05-16 | Dihydroimidazo[1,2-a]pyrimidine derivatives |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0163240A3 (en, 2012) |
JP (1) | JPS60246387A (en, 2012) |
KR (1) | KR850008488A (en, 2012) |
CA (1) | CA1271751A (en, 2012) |
ES (1) | ES8706683A1 (en, 2012) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4918074A (en) * | 1984-03-12 | 1990-04-17 | Yoshitomi Pharmaceutical Industries, Ltd. | Polyazaheterocycle compounds |
EP0217142A3 (en) * | 1985-09-30 | 1988-01-07 | Yoshitomi Pharmaceutical Industries, Ltd. | A polyazaheterocyclic compound |
US4746656A (en) * | 1986-07-21 | 1988-05-24 | E. R. Squibb & Sons, Inc. | 1,2,4,7-tetrahydro-2-oxopyrazolo[1,5-a]pyrimidine derivatives |
US4883872A (en) * | 1987-11-25 | 1989-11-28 | E. R. Squibb & Sons, Inc. | 3-oxo-1,2,4-triazolo(4,3-A) pyrimidine-6-carboxylic acid esters |
US4859676A (en) * | 1988-01-19 | 1989-08-22 | E. R. Squibb & Sons, Inc. | 2-Oxo-1-sulfonyl pyrazolo(1,5-a) pyrimidine-6-carboxylic acid esters |
US4870072A (en) * | 1988-01-19 | 1989-09-26 | E. R. Squibb & Sons, Inc. | 2-oxo-1-substituted pyrazolo[1,5-A]pyrimidine-6-carboxylic acid esters as blood pressure reducing agents |
GB8905130D0 (en) * | 1989-03-07 | 1989-04-19 | Pfizer Ltd | Therapeutic agents |
US6194419B1 (en) | 1997-12-26 | 2001-02-27 | Takeda Chemical Industries, Ltd. | Nitrogen-containing heterocyclic compounds, their production and use |
MY125533A (en) | 1999-12-06 | 2006-08-30 | Bristol Myers Squibb Co | Heterocyclic dihydropyrimidine compounds |
US7772232B2 (en) | 2004-04-15 | 2010-08-10 | Bristol-Myers Squibb Company | Quinazolinyl compounds as inhibitors of potassium channel function |
EP1881986A2 (en) * | 2005-05-12 | 2008-01-30 | Merck & Co., Inc. | Tyrosine kinase inhibitors |
PE20121506A1 (es) * | 2006-07-14 | 2012-11-26 | Amgen Inc | Compuestos triazolopiridinas como inhibidores de c-met |
US8217177B2 (en) | 2006-07-14 | 2012-07-10 | Amgen Inc. | Fused heterocyclic derivatives and methods of use |
US20090012103A1 (en) | 2007-07-05 | 2009-01-08 | Matthew Abelman | Substituted heterocyclic compounds |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3244717A (en) * | 1964-06-18 | 1966-04-05 | Searle & Co | 5-hydroxy-2-methyl-7-phenylimidazo [1, 2-a] pyrimidines |
DE3234684A1 (de) * | 1982-09-18 | 1984-03-22 | Bayer Ag, 5090 Leverkusen | Neue dihydropyrimidine, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln |
JPS5965089A (ja) * | 1982-10-05 | 1984-04-13 | Shionogi & Co Ltd | ジヒドロピラゾロ〔3,4−b〕ピリジン誘導体およびその製造法 |
-
1984
- 1984-05-22 JP JP59104257A patent/JPS60246387A/ja active Granted
-
1985
- 1985-05-16 CA CA000481703A patent/CA1271751A/en not_active Expired - Lifetime
- 1985-05-21 EP EP85106208A patent/EP0163240A3/en not_active Ceased
- 1985-05-21 ES ES543361A patent/ES8706683A1/es not_active Expired
- 1985-05-21 KR KR1019850003488A patent/KR850008488A/ko not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
ES543361A0 (es) | 1987-07-01 |
EP0163240A2 (en) | 1985-12-04 |
JPH0240067B2 (en, 2012) | 1990-09-10 |
KR850008488A (ko) | 1985-12-18 |
JPS60246387A (ja) | 1985-12-06 |
ES8706683A1 (es) | 1987-07-01 |
EP0163240A3 (en) | 1987-04-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2007403C1 (ru) | Способ получения пиразолпиридинового производного или его соли | |
US5698560A (en) | Imidazoquinazoline derivatives | |
US5977118A (en) | 6-substituted pyrazolo[3,4-d]pyrimidin-4-ones and compositions and methods of use thereof | |
KR900007780B1 (ko) | 축합된 피롤리논 유도체의 제조방법 | |
CA1271751A (en) | Dihydroimidazo[1,2-a]pyrimidine derivatives | |
EP0628032A1 (en) | Quinazolinone antianginal agents | |
DK155327B (da) | Analogifremgangsmaade til fremstilling af 5h-2,3-benzodiazepinderivater eller et farmaceutisk acceptabelt syreadditionssalt deraf | |
EP0116769B1 (en) | Dihydropyridines | |
AU708809B2 (en) | 6-aryl pyrazolo{3,4-d}pyrimidin-4-ones and compositions and methods of use thereof | |
EP0077983B1 (en) | Triazine derivatives, processes for preparation thereof and pharmaceutical compositions comprising the same | |
US5217973A (en) | Triazolopyrimidine derivatives which are angiotensin ii receptor antagonists processes for preparing them and pharmaceutical compositions containing them | |
US4861780A (en) | 4(3H)-quinazolinone derivatives and pharmaceutical compositions | |
EP0150469B1 (en) | Thieno(2,3-d)pyrimidine derivatives and salts thereof | |
AU639043B2 (en) | Pyridazine derivatives, process for their preparation and pharmaceutical compositions containing them | |
EP0183848B1 (en) | Polyazaheterocyclic derivatives, process for their preparation, and pharmaceutical composition | |
CA1203801A (en) | Piperazine derivatives, their production and pharmaceutical compositions containing them | |
US4053600A (en) | Tricyclic 1,2,4-triazolo-quinazolines | |
SK99794A3 (en) | Triazolopyrimidine derivatives as antiotensin ii receptor antagonists, method of their preparation, pharmaceutical agent and use | |
CS248720B2 (en) | Production method of quinolines | |
EP0901473B1 (en) | Piperazinylalkylthiopyrimidine derivatives, pharmaceutical compositions containing the same and a process for the preparation of the novel compounds | |
DK158944B (da) | Analogifremgangsmaade til fremstilling af substituerede methylimidazolforbindelser | |
US4028356A (en) | Triazinobenzodiazepines | |
EP0276826A1 (en) | 2-Alkylsulfinyl-4 (3H)-quinazolinone derivatives, processes for their preparation and pharmaceutical compositions | |
JPS61227584A (ja) | ポリアザ複素環誘導体 | |
JP2875605B2 (ja) | 3―エキソメチレンピロロ[2,1―b]チアゾール誘導体 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MKLA | Lapsed |